---
category: listing
circular_id: 675d4670e4acfdfe
date: '2026-02-27'
description: 'Gaudium IVF and Women Health Limited (ticker: 544709) will be added
  to the BSE IPO Index effective March 4, 2026, following its listing on BSE on February
  27, 2026.'
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={61A3CC64-4AD7-4519-8539-0583BC33D2B9}&noticeno=20260227-22&dt=02/27/2026&icount=22&totcount=31&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine index constituent addition following a new IPO listing; affects
  only index-tracking funds and products benchmarked against the BSE IPO Index.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260227-22&attachedId=
processing:
  attempts: 1
  content_hash: f2a662d722e51ca4
  processed_at: '2026-02-27T13:09:36.693602'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-02-27T10:52:42+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={61A3CC64-4AD7-4519-8539-0583BC33D2B9}&noticeno=20260227-22&dt=02/27/2026&icount=22&totcount=31&flag=0
severity: low
source: bse
stocks:
- '544709'
tags:
- index
- bse-ipo-index
- listing
- equity
- index-addition
- '544709'
title: Addition of Gaudium IVF and Women Health Limited to BSE IPO Index
---

## Summary

BSE has announced the addition of Gaudium IVF and Women Health Limited (Exchange ticker: 544709) to the BSE IPO Index. The company was listed on BSE on February 27, 2026, and will be included in the index effective at the open of Wednesday, March 4, 2026.

## Key Points

- Gaudium IVF and Women Health Limited (ticker: 544709) listed on BSE on February 27, 2026.
- The stock will be added to the BSE IPO Index effective March 4, 2026 (market open).
- The corporate action has been included in the end-of-day corporate action file (*.SDE) dated February 27, 2026.
- Reference circular: Notice No. 20260226-41.

## Regulatory Changes

No regulatory changes. This is a routine index rebalancing action following a new listing on BSE.

## Compliance Requirements

Index-linked fund managers, ETF providers, and other entities tracking the BSE IPO Index should update their portfolios to include Gaudium IVF and Women Health Limited (544709) effective at the open of March 4, 2026. Queries may be directed to bseindex@bseindia.com.

## Important Dates

- **February 27, 2026**: Gaudium IVF and Women Health Limited listed on BSE; end-of-day corporate action file (*.SDE) updated.
- **March 4, 2026 (market open)**: Effective date for addition of 544709 to the BSE IPO Index.

## Impact Assessment

The impact is limited to index-tracking products benchmarked against the BSE IPO Index. Fund managers and ETF operators tracking this index will need to incorporate the new constituent. No broader market or regulatory impact is anticipated.